Fundraising Fox

Novel Microdevices

Baltimore, US · Founded 2021 · Delaware corporation

Healthtech

Founders & leadership

Novel Microdevices was founded in 2021 by Andrea Pais.

APAndrea Pais
Andrea PaisinFounderCEO, Co-Founder at Noveldx
RS
Robert StoreyNamed on SEC filing

Board

DH
Deborah HemingwayBoard director
SY
Steve YannarasBoard director
MN
Michael NiggelBoard director

Reported raises · per SEC filings

Form D private placements

$9.2M disclosed across 5 rounds · 2021–2026

▶$1MraisedApr 2026 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrea PaisExecutive Officer, Director
  • Michael NiggelDirector
  • Steve YannarasDirector
Offering amount
$8M
Amount sold
$1M
First sale
Mar 2026
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$567KraisedJan 2025 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrea PaisExecutive Officer, Director
  • Deborah HemingwayDirector
  • Steve YannarasDirector
  • Michael NiggelDirector
Offering amount
$3M
Amount sold
$567K
First sale
Dec 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedJan 2024 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrea PaisExecutive Officer, Director
  • Deborah HemingwayDirector
  • Steve YannarasDirector
Offering amount
$6M
Amount sold
$1.9M
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.4MraisedJan 2023 · 29 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert StoreyDirector
  • Steve YannarasDirector
  • Andrea PaisExecutive Officer, Director
Offering amount
$6.5M
Amount sold
$4.4M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.4MraisedNov 2021 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steve YannarasDirector
  • Andrea PaisExecutive Officer, Director
Offering amount
$2M
Amount sold
$1.4M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Novel Microdevices, Inc. Announces ~$2.7M Follow on Funding from NIH RADx® Techprweb.com · Nov 2024Money Moves: Clean energy financing company Sunstone Credit lands $20M Series A - Technical.lytechnical.ly · Feb 2023Emerging Innovators Q2 Update - California Life Sciencescalifesciences.org · Jun 2021Novel Microdevices wins $13.8M funding award from CARB-X to develop tests for STDstechnical.ly · Apr 2021CARB-X is funding Novel Microdevices to develop a rapid and portable diagnostic for sexually transmitted diseases including antibiotic-resistant infections - Carb-Xcarb-x.org · Apr 2021Novel Microdevices, Inc. awarded up to $13.8 million from CARB-X for the development of a rapid, point-of-care, molecular diagnostic platform for the detection of sexually transmitted diseases, including antibiotic-resistant infectionsprnewswire.com · Apr 2021

Frequently asked questions

Who founded Novel Microdevices?
Novel Microdevices was founded by Andrea Pais in 2021.
How much funding has Novel Microdevices raised?
Novel Microdevices has disclosed $9.2M raised across 5 rounds.
Where is Novel Microdevices headquartered?
Novel Microdevices is headquartered in Baltimore, US.